Latest Publications

Share:

Antitrust in focus - April 2024

Spotlight on below-threshold merger reviews: doubts over European Commission’s powers while in depth probes launched in Italy - Last month, we reported on the landmark Advocate General (AG) opinion in Illumina/GRAIL. The AG...more

The new Italian Annual Market and Competition Law

The Italian Annual Market and Competition Law (Law n. 214/2023, the Law) came into effect on 31 December 2023. The Law aims to foster competition as a driver for efficiency and economic growth, in line with the Italian...more

A step-change in merger control and antitrust enforcement in Italy

IAA granted significant new powers under Italian Annual Market and Competition Law 2021....more

Excessive pricing and orphan drugs: Leadiant sanctioned by the Italian Antitrust Authority

In a long-awaited decision published on 31 May 2021, the IAA found that Leadiant infringed Article 102 TFEU through a multifaceted strategy that led to it obtaining an excessive price for its CDCA Leadiant® medicine. A number...more

Italy fines Leadiant EUR3.5 million for charging excessive prices for an orphan drug

On 31 May 2022, the Italian Competition Authority (ICA) published its decision sanctioning the pharmaceutical company Leadiant EUR3.5 million for charging excessive prices for the sale of an orphan drug....more

Antitrust in focus - April 2022

This newsletter is a summary of the antitrust developments we think are most interesting to your business. Emilio De Giorgi, partner based in Milan, is our editor this month (learn more about Emilio in our Q&A feature at the...more

Antitrust in focus - March 2020

This newsletter is our take on the antitrust developments we think are most interesting to your business. Emilio De Giorgi, head of our Italian antitrust practice, based in Milan, is our editor this month....more

The Italian Antitrust Authority guidelines on compliance programmes

On October 4 the IAA has adopted the guidelines on how to structure an antitrust compliance programme and its treatment in the context of an antitrust investigation. They make clear that only compliance programme satisfying...more

8 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide